News
Filters:
People Don’t Know What ‘Medicare For All’ Means. Democrats Want It That Way.
Next week, Democrats will convene their second round of presidential debates. As during last month’s debate, health care is sure to be a focus. Read More
Dem Push for Government-Run Health Care
Phil Kerpen, President of American Commitment, discusses why there is no reason to trust the same Democrats who gave us ObamaCare with another, even more extreme, version of government-run health… Read More
Biden Goes Half Way to BernieCare
The Democratic debate over single payer is over when, not whether. Read More
America Needs a Pharmaceutical Trade Negotiator
Americans pay significantly more for prescription drugs than patients in other wealthy nations. Read More
V.P. Biden’s Plan is Really a Side Door to Medicare for All
Today, former Vice President and 2020 Democratic presidential candidate Joe Biden offered his healthcare plan, the “Affordable Care Act 2.0.” It would keep and build on Obamacare and provide a public… Read More
Leading Democrats Health Care Proposals Break Hippocratic Oath
The summer heat was far from the only hot air blowing through Miami in June. The blustering Democratic presidential candidates gave taxpayers a close look at their expensive, wasteful, and… Read More
Senate Finance Committee Drug Pricing Changes – Market Driven or More Destructive Price Controls?
The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce… Read More
Don’t Buy The Democrats’ ‘Moderate’ Alternatives To Medicare For All
Democrats appear to be getting skittish about Medicare for All. Read More
Value Our Health: Stop Discriminatory Value Assessments
Millions of Americans are living with chronic illnesses and disabilities. In generations past, we did not live well or long with these conditions. Read More
Binding Arbitration Is Government Price Controls Hiding in Plain Sight
Prescription drug affordability might just be the last truly bipartisan issue in Washington. Read More